1. FDA grants Bristol-Myers priority review for ide-cel — Is Illumina making an $8B blunder? — Medicare may not cover the cost of the coronavirus vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

CNS Therapeutics

Discussion in 'Neurology' started by Anonymous, May 10, 2012 at 2:49 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Has any one heard about this company? A recruiter called me to sell their generic injection.
     

  2. Anonymous

    Anonymous Guest

    A well-funded private company with a great CEO and growing revenues, market share and pipeline of products coming next few years. Demanding sales quotas but good incentives for performance...